These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9280301)

  • 1. An AU at the first base pair of helix 3 elevates the catalytic activity of hepatitis delta virus ribozymes.
    Huang ZS; Ping YH; Wu HN
    FEBS Lett; 1997 Aug; 413(2):299-303. PubMed ID: 9280301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro selection analysis of trans-acting HDV ribozyme.
    Nishikawa F; Chiba A; Shirai M; Fauzi H; Taira K; Kumar PK; Nishikawa S
    Nucleic Acids Symp Ser; 1995; (34):115-6. PubMed ID: 8841579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic characterization of the HDV genomic ribozyme: the cleavage site base pair plays a structural role in facilitating catalysis.
    Cerrone-Szakal AL; Chadalavada DM; Golden BL; Bevilacqua PC
    RNA; 2008 Sep; 14(9):1746-60. PubMed ID: 18658121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection in vitro of trans-acting genomic human hepatitis delta virus (HDV) ribozymes.
    Nishikawa F; Kawakami J; Chiba A; Shirai M; Kumar PK; Nishikawa S
    Eur J Biochem; 1996 May; 237(3):712-8. PubMed ID: 8647117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic strategies of the hepatitis delta virus ribozymes.
    Shih IH; Been MD
    Annu Rev Biochem; 2002; 71():887-917. PubMed ID: 12045114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A nested double pseudoknot is required for self-cleavage activity of both the genomic and antigenomic hepatitis delta virus ribozymes.
    Wadkins TS; Perrotta AT; Ferré-D'Amaré AR; Doudna JA; Been MD
    RNA; 1999 Jun; 5(6):720-7. PubMed ID: 10376872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of an HDV ribozyme which consists of three RNA oligomer strands.
    Sakamoto T; Kuwabara T; Tanaka Y; Kurihara Y; Katahira M; Uesugi S
    Nucleic Acids Symp Ser; 1995; (34):131-2. PubMed ID: 8841587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Constructing an efficient trans-acting genomic HDV ribozyme.
    Kawakami J; Yuda K; Suh YA; Kumar PK; Nishikawa F; Maeda H; Taira K; Ohtsuka E; Nishikawa S
    FEBS Lett; 1996 Sep; 394(2):132-6. PubMed ID: 8843150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of HDV ribozymes to trans-cleave HCV RNA.
    Yu YC; Mao Q; Gu CH; Li QF; Wang YM
    World J Gastroenterol; 2002 Aug; 8(4):694-8. PubMed ID: 12174380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribozymes of the hepatitis delta virus: recent findings on their structure, mechanism of catalysis and possible applications.
    Ciesiolka J; Wrzesinski J; Legiewicz M; Smólska B; Dutkiewicz M
    Acta Biochim Pol; 2001; 48(2):409-18. PubMed ID: 11732611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical probing studies of the hepatitis delta virus (HDV) genomic ribozyme.
    Nishikawa S; Kumar PK; Jeoung YH; Kawakami J; Nishikawa F; Suh Y; Ohtsuka E; Taira K
    Nucleic Acids Symp Ser; 1993; (29):119-20. PubMed ID: 8247731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic Parameters of trans Scission by Extended HDV-like Ribozymes and the Prospect for the Discovery of Genomic trans-Cleaving RNAs.
    Webb CT; Lupták A
    Biochemistry; 2018 Mar; 57(9):1440-1450. PubMed ID: 29388767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic cleavage of cis- and trans-acting antigenomic delta ribozymes in the presence of various divalent metal ions.
    Wrzesinski J; Legiewicz M; Smólska B; Ciesiolka J
    Nucleic Acids Res; 2001 Nov; 29(21):4482-92. PubMed ID: 11691936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of the P1.1 pseudoknot is critical for both the cleavage activity and substrate specificity of an antigenomic trans-acting hepatitis delta ribozyme.
    Deschênes P; Ouellet J; Perreault J; Perreault JP
    Nucleic Acids Res; 2003 Apr; 31(8):2087-96. PubMed ID: 12682359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis delta virus ribozymes fold to generate a solvent-inaccessible core with essential nucleotides near the cleavage site phosphate.
    Rosenstein SP; Been MD
    Biochemistry; 1996 Sep; 35(35):11403-13. PubMed ID: 8784196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terbium-mediated footprinting probes a catalytic conformational switch in the antigenomic hepatitis delta virus ribozyme.
    Harris DA; Tinsley RA; Walter NG
    J Mol Biol; 2004 Aug; 341(2):389-403. PubMed ID: 15276831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cis- and trans-acting ribozymes from a human pathogen, hepatitis delta virus.
    Been MD
    Trends Biochem Sci; 1994 Jun; 19(6):251-6. PubMed ID: 8073503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel structural rearrangement of hepatitis delta virus antigenomic ribozyme.
    Nehdi A; Perreault J; Beaudoin JD; Perreault JP
    Nucleic Acids Res; 2007; 35(20):6820-31. PubMed ID: 17933779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A three-dimensional model of hepatitis delta virus ribozyme based on biochemical and mutational analyses.
    Tanner NK; Schaff S; Thill G; Petit-Koskas E; Crain-Denoyelle AM; Westhof E
    Curr Biol; 1994 Jun; 4(6):488-98. PubMed ID: 7922369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The folding pathway of the genomic hepatitis delta virus ribozyme is dominated by slow folding of the pseudoknots.
    Chadalavada DM; Senchak SE; Bevilacqua PC
    J Mol Biol; 2002 Apr; 317(4):559-75. PubMed ID: 11955009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.